Post-Surgery Complications Treatment (RecoSMA® on the MULTILINE™ Platform)

Post-operative problems—scarring, tissue necrosis, poor wound healing, wound infection, hematoma, seroma, wound dehiscence, and ectropion—need fast, tissue-sparing solutions. LINLINE’s approach combines precise Er:YAG “ablative sanitation” to clean and vitalize the wound bed with RecoSMA® field therapy to accelerate true regeneration (neovascularization, collagen remodeling, functional tissue replacement). 

Why this method works

• Battle infection & biofilm, safely remove necrosis. Short-pulse Er:YAG 2.94 μm removes slough, fibrin, necrotic tissue and biofilm layer-by-layer under direct vision (≤~100 μm/pass) without deep thermal trauma—“blood-dew” confirms a clean, vital wound bed.
• Trigger rapid, deep regeneration (non-thermal). RecoSMA® creates surface micro-events that launch acoustic waves reaching up to ~6 mm into tissue; waves converge to disrupt fibrotic structures, induce new capillary growth, and stimulate functional tissue to replace damaged areas—without heating the skin.
• Prevent excessive scarring. Early RecoSMA® shifts healing toward regeneration rather than fibrosis; scar prevention is strongest when started as early as week 1 (clinician-guided). 

Indications we address

• Scarring (hypertrophic / normotrophic, prevention & treatment)
• Tissue necrosis (post-facelift, mastopexy, abdominoplasty; filler-related ischemic necrosis)
• Poor wound healing & wound dehiscence
• Wound infection
• Hematoma / Seroma (e.g., post-blepharoplasty)
• Ectropion (post-blepharoplasty lid malposition) 

How a treatment course looks

1. Ablative sanitation (Er:YAG)
   Layer-controlled removal of non-viable tissue and biofilm until the wound bed is clean and vital; repeat as needed early in the course.
2. RecoSMA® field therapy
   SMA pass across the wound and 0.5–1 cm around the margins to stimulate granulation, neovascularization, and remodeling; sessions repeated according to response.
3. Adjunct TCT therapy (when indicated for scars)
   A single Nd:YAP/KTP session may be used to reduce vascular supply in hypertrophic scars, followed by RecoSMA® to remodel fibrosis.

What patients feel & recovery

• During: sanitation is usually well-tolerated; RecoSMA® is non-thermal (skin remains ~36.6 °C) but warmth/tingling can build for a few minutes as blood flow increases.
• After: dry sterile dressing; avoid scratching ~5 days; limit sun ~1 week. With progressive granulation and epithelization, visit frequency tapers from daily/every-other-day to weekly. 

What we see in practice

• Tissue necrosis (post-mastopexy/facelift/abdominoplasty):
  Clean with Er:YAG (2–5 sessions) → RecoSMA® (3–6 sessions). Complete healing reported in 17–33 days depending on size, smoking history, and depth.
• Ischemic necrosis after filler embolism:
  RecoSMA® started early achieved closure in 10–14 days in presented cases.
• Wound dehiscence / infected wounds:
  Daily sanitation + staged RecoSMA® prepared for secondary sutures in ~3–14 days, with full closure typically within 17–64 days, sometimes alongside VAC therapy.
• Seroma after blepharoplasty:
  1 session of RecoSMA® led to clinical resolution in showcased cases.
• Ectropion (post-blepharoplasty):
  1–2 weekly RecoSMA® sessions improved lower-lid position and tone in the deck’s examples.
• Hypertrophic scarring:
  Example: Nd:YAP/KTP (1 session) + RecoSMA® (1 session) after blepharoplasty improved scar quality and appearance. 

How we tailor by complication

• Scarring (treatment & prevention): begin early when possible; RecoSMA® sessions promote functional tissue replacement and soften borders; add TCT if the scar is highly vascular.
• Tissue necrosis / poor healing: sanitation first; RecoSMA® to jump-start granulation and normalize microcirculation; consider closure once the bed is clean and granulating.
• Infection: sanitation reduces microbial load and biofilm; RecoSMA® supports perfusion and host response—then reassess for closure.
• Hematoma / Seroma: RecoSMA® improves local microcirculation and lymph dynamics; evacuate/aspirate when clinically required, then stimulate orderly healing.
• Dehiscence: iterative sanitation + RecoSMA® to obtain a robust bed, then secondary sutures when ready.
• Ectropion: RecoSMA® to improve dermal elasticity and support (often 1–2 sessions), with shields and conservative settings on eyelids. 

Safety & practical notes

• Choose Er:YAG for sanitation (microsecond pulses) to avoid deep thermal damage typical of hot CO₂ debridement.
• RecoSMA® is non-thermal and barrier-sparing; discomfort is managed by reducing frequency, not energy.
• Etiology still matters: combine with compression, unloading, revascularization, antibiotics, or VAC per standard of care.
• Eyelids: always use laser shields. 

Benefits at a glance

For patients

• Faster, cleaner healing with less collateral trauma.
• Reduced risk of excessive scarring and improved cosmetic outcomes.
• Short, predictable aftercare; many cases progress to closure sooner. 

For practitioners

• Reproducible endpoints: “blood-dew” for sanitation; granulation/epithelization after RecoSMA®.
• Versatility: effective across necrosis, infection, seroma/hematoma, dehiscence, ectropion, and scar management.
• Platform simplicity: all steps delivered on the MULTILINE™ base unit. 

Key takeaway

With Er:YAG sanitation to clean the field and RecoSMA® to accelerate non-thermal regeneration—plus TCT when scar vascularity needs to be reduced—LINLINE offers a cohesive, platform-based pathway to manage post-surgery complications quickly, comfortably, and with a strong focus on natural-looking outcomes.